[PTEN loss correlates withthe clinical efficacy of lapatinib in HER2 positive metastatic breast cancer with trastuzumab-resistance]. (Q55033275)
Jump to navigation
Jump to search
scientific article published in July 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | [PTEN loss correlates withthe clinical efficacy of lapatinib in HER2 positive metastatic breast cancer with trastuzumab-resistance]. |
scientific article published in July 2015 |
Statements
[PTEN loss correlates withthe clinical efficacy of lapatinib in HER2 positive metastatic breast cancer with trastuzumab-resistance]. (English)
1 reference
Ge Du
1 reference
Li Bian
1 reference
Tao Wang
1 reference
Xiaojie Xu
1 reference
Shaohua Zhang
1 reference
Yunfei Guo
1 reference
Jinmei Zhuo
1 reference
Santai Song
1 reference
Zefei Jiang
1 reference
1 July 2015
1 reference
95
1 reference
28
1 reference
2264-2267
1 reference